Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dihua Yu

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Cancer Research|November 8, 2013
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferationSumaiyah K Rehman, Shau-Hsuan Li, Shannon L Wyszomierski, et al.
Oncotarget|February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell linesMajid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Acta Neuropathologica|January 4, 2021
Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasisKazutaka Fukumura, Prit Benny Malgulwar, Grant M Fischer, et al.
Nature Cell Biology|February 22, 2011
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAsChun-Ju Chang, Chi-Hong Chao, Weiya Xia, et al.
Cancer Research|April 6, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell FunctionXixi Zhao, Yongkun Wei, Yu-Yi Chu, et al.
Cancer Research|August 19, 2017
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic CellsVictor A Gall, Anne V Philips, Na Qiao, et al.
Acta Pharmaceutica Sinica. B|March 7, 2022
miR-7/TGF-<i>β2</i> axis sustains acidic tumor microenvironment-induced lung cancer metastasisTao Su, Suchao Huang, Yanmin Zhang, et al.
Science Translational Medicine|May 29, 2020
Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastasesLin Zhang, Jun Yao, Yongkun Wei, et al.
Molecular Oncology|December 2, 2014
HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancerDelphine R Boulbes, Stefan T Arold, Gaurav B Chauhan, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Cancer Research|November 8, 2013
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferationSumaiyah K Rehman, Shau-Hsuan Li, Shannon L Wyszomierski, et al.
Oncotarget|February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell linesMajid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Acta Neuropathologica|January 4, 2021
Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasisKazutaka Fukumura, Prit Benny Malgulwar, Grant M Fischer, et al.
Nature Cell Biology|February 22, 2011
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAsChun-Ju Chang, Chi-Hong Chao, Weiya Xia, et al.
Cancer Research|April 6, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell FunctionXixi Zhao, Yongkun Wei, Yu-Yi Chu, et al.
Cancer Research|August 19, 2017
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic CellsVictor A Gall, Anne V Philips, Na Qiao, et al.
Acta Pharmaceutica Sinica. B|March 7, 2022
miR-7/TGF-<i>β2</i> axis sustains acidic tumor microenvironment-induced lung cancer metastasisTao Su, Suchao Huang, Yanmin Zhang, et al.
Science Translational Medicine|May 29, 2020
Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastasesLin Zhang, Jun Yao, Yongkun Wei, et al.
Molecular Oncology|December 2, 2014
HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancerDelphine R Boulbes, Stefan T Arold, Gaurav B Chauhan, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Pageof 16